Milan and the Lombardy region stand as the beating heart of Italy's pharmaceutical industry, representing over 60% of the national biotech turnover. As a premier Peptide APIs Exporter for Milan, Gentolex recognizes the city's role as a global node for clinical excellence. The local landscape is characterized by high-density R&D clusters, such as the Milan Innovation District (MIND), where advanced peptide synthesis meets cutting-edge drug delivery systems.
The global peptide therapeutic market is projected to exceed $50 billion by 2027. This growth is driven by the increasing prevalence of metabolic disorders, oncology advancements, and the rise of "Green Chemistry" in peptide synthesis. Gentolex Group bridges the gap between massive manufacturing scale and the precise requirements of European regulatory standards (EMA).
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
The future of Peptide APIs lies in Solid-Phase Peptide Synthesis (SPPS) optimization and Liquid-Phase (LPPS) hybrid models. We are currently integrating AI-driven molecular modeling to predict peptide stability in varied formulations, ensuring that our products for the Milan market are optimized for shelf-life and bioavailability.
High-Purity Selank Acetate API | Peptide Manufacturing and Global Supply for neurological research.
Professional Thymosin Beta-4 API manufacturer providing high-purity Tβ4 for tissue repair.
Mitochondria-targeting tetrapeptide designed to stabilize cellular bioenergetics.
A: All our APIs are produced in cGMP-compliant facilities, meeting EP (European Pharmacopoeia) and USP standards, ensuring full compliance with Italian AIFA and EMA regulations.
A: Yes, we provide full technical consultation, including lab setup, product line design, and FDF (Finished Dosage Form) licensing out services for Italian biotech firms.
A: We utilize validated cold-chain solutions with real-time temperature tracking to ensure peptide stability from our facility to your doorstep in Milan.
